Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Protalix BioTherapeutics ...

    AMEX: PLX · Real-Time Price · USD
    1.47
    -0.05 (-3.29%)
    At close: Aug 15, 2025, 2:13 PM

    Protalix BioTherapeutics Revenue

    Protalix BioTherapeutics reported an annual revenue of $53.4M, reflecting a -18.47% growth. For the quarter ending March 31, 2025, Protalix BioTherapeutics generated $10.11M in revenue.
    Revenue (ttm)
    53.4M
    Revenue Growth
    -18.47%
    Price / Sales Ratio
    2.55
    Revenue / Employee
    250.7K
    Employees
    213
    Market Cap
    117.02M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist